Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01434602
Title Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

high grade glioma

gliosarcoma

glioblastoma

malignant astrocytoma

oligodendroglioma

mixed oligodendroglioma-astrocytoma

Therapies

Everolimus + Sorafenib

Age Groups: adult
Covered Countries USA


No variant requirements are available.